Repligen expands process analytics portfolio with DRS Daylig

Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, today announced it has entered into a strategic partnership and exclusive license agreement with DRS Daylight Solutions to expand the use of mid-infrared (mid-IR) technology in the bioprocessing market.

Related Keywords

Tony Hunt , Emily Magee , Repligen Corporation , Analytics Technology , Daylight Solutions , Daylight Solutions Incsep , From Daylight Solutions Incsep , Quantum Cascade Laser , Repligen Chromatography , Process Analytics Technology , Diego Based Daylight , Tim Day , Timothy Day , Senior Vice President , General Manager , Bioprocessing , Manufacturing , Ucleic Acid , Protein ,